Literature DB >> 11369692

Beta(3)-integrin-deficient mice but not P-selectin-deficient mice develop intimal hyperplasia after vascular injury: correlation with leukocyte recruitment to adherent platelets 1 hour after injury.

S S Smyth1, E D Reis, W Zhang, J T Fallon, R E Gordon, B S Coller.   

Abstract

BACKGROUND: Intimal hyperplasia contributes to restenosis after percutaneous vascular interventions. Both beta(3)-integrins, alpha(V)beta(3) and alpha(IIb)beta(3) (glycoprotein IIb/IIIa), and leukocytes have been implicated in neointimal formation, based in part on the results obtained using antagonists to 1 or both receptors in animal models. METHODS AND
RESULTS: The responses in wild-type mice, beta(3)-integrin-deficient mice, and P-selectin-deficient mice were studied in a model of transluminal endothelial injury of the femoral artery. At 4 weeks, beta(3)-integrin-deficient mice were not protected from developing intimal hyperplasia, whereas P-selectin-deficient mice were protected. Within 1 hour of injury, several layers of platelets deposited on the arteries of wild-type mice and a single layer of platelets deposited on the vessels of beta(3)-integrin-deficient mice; in both cases, leukocytes were recruited to the platelet layer. In P-selectin-deficient mice, the platelet layer was less compact and extended further into the lumen but did not recruit leukocytes.
CONCLUSIONS: In a model of transluminal arterial injury, absence of early leukocyte recruitment and not deficiency of beta(3)-integrins correlated with a reduction in neointimal formation. Blockade of P-selectins may be an effective therapeutic strategy to decrease restenosis after percutaneous vascular interventions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11369692     DOI: 10.1161/01.cir.103.20.2501

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  35 in total

1.  Regulation of vascular smooth muscle cell growth: targeting the final common pathway.

Authors:  Angela M Taylor; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-01       Impact factor: 8.311

Review 2.  Platelet-leukocyte interactions in cardiovascular disease and beyond.

Authors:  Licia Totani; Virgilio Evangelista
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

3.  Src family kinases mediate neutrophil adhesion to adherent platelets.

Authors:  Virgilio Evangelista; Zehra Pamuklar; Antonio Piccoli; Stefano Manarini; Giuseppe Dell'elba; Romina Pecce; Nicola Martelli; Lorenzo Federico; Mauricio Rojas; Giorgio Berton; Clifford A Lowell; Licia Totani; Susan S Smyth
Journal:  Blood       Date:  2006-11-09       Impact factor: 22.113

Review 4.  The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend.

Authors:  Barry S Coller; Sanford J Shattil
Journal:  Blood       Date:  2008-10-15       Impact factor: 22.113

5.  The intrinsic complement regulator decay-accelerating factor modulates the biological response to vascular injury.

Authors:  Masashi Sakuma; Toshifumi Morooka; Yunmei Wang; Can Shi; Kevin Croce; Huiyun Gao; Michael Strainic; M Edward Medof; Daniel I Simon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-03-18       Impact factor: 8.311

6.  Vascular smooth muscle cell motility: From migration to invasion.

Authors:  Sherif F Louis; Peter Zahradka
Journal:  Exp Clin Cardiol       Date:  2010

7.  Human solCD39 inhibits injury-induced development of neointimal hyperplasia.

Authors:  J H F Drosopoulos; R Kraemer; H Shen; R K Upmacis; A J Marcus; E Musi
Journal:  Thromb Haemost       Date:  2009-12-18       Impact factor: 5.249

8.  Platelet IκB kinase-β deficiency increases mouse arterial neointima formation via delayed glycoprotein Ibα shedding.

Authors:  Shujian Wei; Huan Wang; Guoying Zhang; Ying Lu; Xiaofei An; Shumei Ren; Yunmei Wang; Yuguo Chen; James G White; Chunxiang Zhang; Daniel I Simon; Chaodong Wu; Zhenyu Li; Yuqing Huo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12-13       Impact factor: 8.311

9.  Actual Role of Platelet Glycoprotein IIb/IIIa Receptor Inhibitors as Adjunctive Pharmacological Therapy to Primary Angioplasty in Acute Myocardial Infarction: In the Light of Recent Randomized Trials and Observational Studies with Bivalirudin.

Authors:  Osmar Antonio Centurión
Journal:  Open Cardiovasc Med J       Date:  2010-06-17

10.  Decreased neointimal formation in Nox2-deficient mice reveals a direct role for NADPH oxidase in the response to arterial injury.

Authors:  Zhiping Chen; John F Keaney; Eberhard Schulz; Bruce Levison; Lian Shan; Masashi Sakuma; Xiaobin Zhang; Can Shi; Stanley L Hazen; Daniel I Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.